glp-1 for menopause weight loss | Provider-Led GLP-1 Weight-Loss Drugs and Menopause:

Specifically, 40% in the 0.1-mg group, 36% in the 0.2-mg group, and 59% in the 0.4-mg group achieved this endpoint, compared to just 17% receiving placebo

Celsa C, Pennisi G, Tulone A, et al

Spencer Nadolsky, an obesity medicine physician, tells Yahoo Life

"Experimental Drug Yields Dramatic Weight Loss"

The steady-state mean plasma AUC and Cmax were 1,870 nmolh/L and 259 nmol/L, respectively, with 10 mg empagliflozin once daily treatment, and 4,740 nmolh/L and 687 nmol/L, respectively, with 25 mg empagliflozin once daily treatment

18 However, its rapid hydrolysis by intestinal lactase and SGLT1 inhibition causing diarrhea limited its clinical use